| Prev Close: | 47.34 |
|---|
| Open: | N/A |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 48.29 |
|---|
| Beta: | 0.78 |
|---|
| Next Earnings Date: | 1-Aug-13 |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 29.82 - 51.40 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 1,015,780 |
|---|
| Market Cap: | 6.74B |
|---|
| P/E (ttm): | 22.19 |
|---|
| EPS (ttm): | 2.13 |
|---|
| Div & Yield: | 0.68 (1.40%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- ResMed Inc. (RMD): Today's Featured Health Services Laggardat TheStreet(Thu, Jun 6)
- ResMed Takes Action to Enforce Patents Against BMC and 3BPR Newswire(Wed, Jun 5)
- Twin Launch by ResMedZacks(Tue, Jun 4)
- 3 Health Services Stocks Pushing The Industry Higherat TheStreet(Tue, Jun 4)
- ResMed: More Signals That It's Time To Take Profitat Seeking Alpha(Tue, Jun 4)
- ResMed's New Ultra-lightweight Quattro™ Air Offers a Higher Level of Comfort and ConveniencePR Newswire(Mon, Jun 3)
- ResMed Launches SleepSeeker Online Tool to Increase Patient Engagement in Therapy for Sleep-Disordered BreathingPR Newswire(Mon, Jun 3)
- One Year After The IPO, Is Facebook Already Becoming A New Economy Dog?at Forbes(Sun, May 19)
- 4 Stocks Going Ex-Dividend Tomorrow: SLH, STO, RMD, RCLat TheStreet(Thu, May 16)
- ResMed Stock To Go Ex-dividend Tomorrow (RMD)at TheStreet(Thu, May 16)
- FMS, COO, RMD, THC And HCA, Pushing Health Services Industry Downwardat TheStreet(Wed, May 15)
- ResMed (RMD) Goes Ex-Dividend Soonat Forbes(Wed, May 15)
- X Factor: 5 Stocks Reaching Their Ex-Dividend Date on May 17at Minyanville(Fri, May 10)
- Cashed-Up ResMed Mulls $1 Billion Questionat The Wall Street Journal(Thu, May 9)
- ResMed Stock Hits New 52-Week High (RMD)at TheStreet(Wed, May 8)
Key Statistics
| Forward P/E (1 yr): | 19.01 |
|---|
| P/S (ttm): | 4.58 |
|---|
| Ex-Dividend Date: | 17-May-13 |
|---|
Analysts
| Annual EPS Est
(Jun-13)
: | 2.25 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.62 |
|---|
| Mean Recommendation*: | 2.5 |
|---|
| PEG Ratio (5 yr expected): | 1.35 |
|---|
Business Summary
ResMed Inc., through its subsidiaries, engages in the development, manufacture, and distribution of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders.
View More